abstract |
Conditionally active receptor agonists that, when activated, bind to IL-2 receptor βṾ c heterodimer (IL-2RβṾ c ), 1L-4 receptor αṾ c heterodimer (IL-4RαṾ c ), or IL-13 receptor a subunit (IL~13 Rα) are disclosed, as are components of the conditionally active receptor agonists and methods for using the conditionally active receptor agonists. |